drugset / Trial / NCT02037893

Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media

NCT02037893

Phase 2 Completed 112 enrolled Currax Pharmaceuticals
RandomizedFactorialTriple-blindTreatment

Summary

The primary objective is to compare the effect of treatment with a combination of ear solutions on the reduction of pain symptoms at 1 hour after dosing in children with acute otitis media.

Timeline

Start
2013-11
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Antipyrine Small molecule 54 mg Other
Comparator Benzocaine Small molecule 14 mg Other

Indications